Interaction of PAH-related compounds with the α and β isoforms of the estrogen receptor

被引:107
作者
Fertuck, KC
Kumar, S
Sikka, HC
Matthews, JB
Zacharewski, TR
机构
[1] Michigan State Univ, Dept Biochem & Mol Biol, Natl Food Safety & Toxicol Ctr, E Lansing, MI 48824 USA
[2] Michigan State Univ, Inst Environm Toxicol, E Lansing, MI 48824 USA
[3] SUNY Coll Buffalo, Great Lakes Ctr, Environm Toxicol & Chem Lab, Buffalo, NY 14222 USA
关键词
estrogen receptor; estrogenic endocrine disrupter; PAHs; heterocyclic PAHs; monohydroxy PAHs;
D O I
10.1016/S0378-4274(01)00344-7
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The ability of several 4- and 5-ring polycyclic aromatic hydrocarbons (PAHs), heterocyclic PAHs. and their monohydroxy derivatives to interact with the estrogen receptor (ER) alpha and beta isoforms was examined. Only compounds possessing a hydroxyl group were able to compete with H-3-labeled 17 beta -estradiol(E2) for binding to either a glutathione-S-transferase and human ER alpha D, E, and F domain fusion protein (GST-hER alpha def) or to the full-length human ERP. Competitive binding was comparable for both isoforms, with IC,, values ranging from 20 to 300 nM (E2 IC50, approximately 3 nM). However, several compounds were able to induce reporter gene expression preferentially through mER beta, using MCF-7 cells transiently transfected with either a Ga14-human ER alpha def or Gal4-mouse ER beta def construct, as well as a Gal4-regulated reporter. These data extend the number and type of PAM-related compounds capable of interacting with ER alpha and ER beta, and provides additional evidence that even though some compounds may possess a similar affinity for both ER isoforms. the capacity for transcriptional activation can still be isoform-specific. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:167 / 177
页数:11
相关论文
共 56 条
[1]   Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells [J].
Arcaro, KF ;
O'Keefe, PW ;
Yang, Y ;
Clayton, W ;
Gierthy, JF .
TOXICOLOGY, 1999, 133 (2-3) :115-127
[2]   Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists [J].
Barkhem, T ;
Carlsson, B ;
Nilsson, Y ;
Enmark, E ;
Gustafsson, JÅ ;
Nilsson, S .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :105-112
[3]   OXIDATION OF BENZO[A]PYRENE BY RECOMBINANT HUMAN CYTOCHROME-P450 ENZYMES [J].
BAUER, E ;
GUO, ZY ;
UENG, YF ;
BELL, LC ;
ZELDIN, D ;
GUENGERICH, FP .
CHEMICAL RESEARCH IN TOXICOLOGY, 1995, 8 (01) :136-142
[4]   THE AH REGULATORY GENE-PRODUCT - SURVEY OF 19 POLYCYCLIC AROMATIC-COMPOUNDS AND .15. BENZO[A]PYRENE METABOLITES CAPACITY TO BIND TO THE CYTOSOLIC RECEPTOR [J].
BIGELOW, SW ;
NEBERT, DW .
TOXICOLOGY LETTERS, 1982, 10 (01) :109-118
[5]   The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands [J].
Blair, RM ;
Fang, H ;
Branham, WS ;
Hass, BS ;
Dial, SL ;
Moland, CL ;
Tong, WD ;
Shi, LM ;
Perkins, R ;
Sheehan, DM .
TOXICOLOGICAL SCIENCES, 2000, 54 (01) :138-153
[6]  
BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116
[7]   POLYNUCLEAR AROMATIC HYDROCARBON CARCINOGENS AS ANTIESTROGENS IN MCF-7 HUMAN BREAST-CANCER CELLS - ROLE OF THE AH RECEPTOR [J].
CHALOUPKA, K ;
KRISHNAN, V ;
SAFE, S .
CARCINOGENESIS, 1992, 13 (12) :2233-2239
[8]  
CHARLES GD, 1999, TOXICOL SCI, V14, P207
[9]   THE INTER-RELATIONSHIPS BETWEEN OVARIAN-INDEPENDENT GROWTH, TUMORIGENICITY, INVASIVENESS AND ANTIOESTROGEN RESISTANCE IN THE MALIGNANT PROGRESSION OF HUMAN-BREAST CANCER [J].
CLARKE, R ;
BRUNNER, N ;
THOMPSON, EW ;
GLANZ, P ;
KATZ, D ;
DICKSON, RB ;
LIPPMAN, ME .
JOURNAL OF ENDOCRINOLOGY, 1989, 122 (01) :331-340
[10]   Evidence of estrogen- and TCDD-like activities in crude and fractionated extracts of PM10 air particulate material using in vitro gene expression assays [J].
Clemons, JH ;
Allan, LM ;
Marvin, CH ;
Wu, Z ;
McCarry, BE ;
Bryant, DW ;
Zacharewski, TR .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 1998, 32 (12) :1853-1860